The Medicines and Healthcare Products Regulatory Agency of the United Kingdom announced a phased withdrawal of co-proxamol because?



 A    of a high fatality rate due to overdose

B    it contains an unacceptable amount of codeine

C    it was available as a non-prescription medicine

D    it presented manufacturing difficulties

E    it causes addiction


  1. A is the answer, and winners are :Nwaki Christopher and Fadeelet.
    Details below:
    Co-proxamol consists of a combination of dextropropoxyphene and paracetamol. In the United Kingdom, the Medicines and Healthcare Products Regu￾latory Agency has announced a phased withdrawal of co-proxamol because
    of a high fatality rate caused by overdose. It was reported to be a prescrip￾tion product commonly associated with death. In overdosage, which may be
    combined with alcohol consumption, respiratory depression and acute heart
    failure occur because of the dextropropoxyphene component and hepatoxicity
    occurs due to paracetamol.